K P Richter

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. ncbi Good and bad times for treating cigarette smoking in drug treatment
    Kimber P Richter
    Department of Preventive Medicine and Public Health, University of Kansas School of Medicine, Kansas City, MO, USA
    J Psychoactive Drugs 38:311-5. 2006
  2. ncbi A case for addressing cigarette use in methadone and other opioid treatment programs
    K P Richter
    Department of Preventive Medicine, University of Kansas School of Medicine, Kansas City 66160 7303, USA
    J Addict Dis 19:35-52. 2000
  3. ncbi Patterns of smoking and methadone dose in drug treatment patients
    Kimber P Richter
    Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, KS 66160 7313, USA
    Exp Clin Psychopharmacol 15:144-53. 2007
  4. ncbi A rationale and model for addressing tobacco dependence in substance abuse treatment
    Kimber P Richter
    Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, Kansas, USA
    Subst Abuse Treat Prev Policy 1:23. 2006
  5. ncbi Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients
    Kimber P Richter
    Department of Preventative Medicine and Public Health, 3901 Rainbow Boulevard, Mail Stop 1008, Kansas City, KS 66160, USA
    J Addict Dis 24:79-90. 2005
  6. ncbi Smoking policies in U.S. outpatient drug treatment facilities
    Kimber P Richter
    University of Kansas Medical School and Kansas Cancer Institute, Kansas City, KS 66160, USA
    Nicotine Tob Res 7:475-80. 2005
  7. ncbi Cigarette smoking among marijuana users in the United States
    Kimber P Richter
    Department of Preventive Medicine and Public Health, University of Kansas Medical Cetner, 3901 Rainbow Boulevard, Mail Stop 1008, Kansas City, KS 66160 7313, USA
    Subst Abus 25:35-43. 2004
  8. ncbi Smoking cessation services in U.S. methadone maintenance facilities
    Kimber P Richter
    Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Mail Stop 1008, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
    Psychiatr Serv 55:1258-64. 2004
  9. ncbi Patients' views on smoking cessation and tobacco harm reduction during drug treatment
    Kimber Paschall Richter
    Department of Preventive Medicine and Kansas Cancer Institute, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA
    Nicotine Tob Res 4:S175-82. 2002
  10. ncbi A hierarchy of strategies heroin-using mothers employ to reduce harm to their children
    K P Richter
    Department of Preventive Medicine, University of Kansas Medical School, 3901 Rainbow Boulevard, Kansas City, KS 66160 7313, USA
    J Subst Abuse Treat 19:403-13. 2000

Detail Information

Publications18

  1. ncbi Good and bad times for treating cigarette smoking in drug treatment
    Kimber P Richter
    Department of Preventive Medicine and Public Health, University of Kansas School of Medicine, Kansas City, MO, USA
    J Psychoactive Drugs 38:311-5. 2006
    ..One tactic for disseminating tobacco treatment in drug treatment might involve identifying the purported benefits of tobacco and training providers in alternative methods for delivering these benefits...
  2. ncbi A case for addressing cigarette use in methadone and other opioid treatment programs
    K P Richter
    Department of Preventive Medicine, University of Kansas School of Medicine, Kansas City 66160 7303, USA
    J Addict Dis 19:35-52. 2000
    ....
  3. ncbi Patterns of smoking and methadone dose in drug treatment patients
    Kimber P Richter
    Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, KS 66160 7313, USA
    Exp Clin Psychopharmacol 15:144-53. 2007
    ..Future research should use experimental designs to better examine whether a causal relationship exists and examine the impact of other types of opioid maintenance medications on smoking patterns...
  4. ncbi A rationale and model for addressing tobacco dependence in substance abuse treatment
    Kimber P Richter
    Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Kansas City, Kansas, USA
    Subst Abuse Treat Prev Policy 1:23. 2006
    ....
  5. ncbi Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients
    Kimber P Richter
    Department of Preventative Medicine and Public Health, 3901 Rainbow Boulevard, Mail Stop 1008, Kansas City, KS 66160, USA
    J Addict Dis 24:79-90. 2005
    ....
  6. ncbi Smoking policies in U.S. outpatient drug treatment facilities
    Kimber P Richter
    University of Kansas Medical School and Kansas Cancer Institute, Kansas City, KS 66160, USA
    Nicotine Tob Res 7:475-80. 2005
    ..Only 1 in 10 ban smoking. Outpatient facilities should restrict or ban outdoor tobacco use in order to remain consistent with their mission and avoid sabotaging clinic efforts to treat, and patient and staff efforts to stop, smoking...
  7. ncbi Cigarette smoking among marijuana users in the United States
    Kimber P Richter
    Department of Preventive Medicine and Public Health, University of Kansas Medical Cetner, 3901 Rainbow Boulevard, Mail Stop 1008, Kansas City, KS 66160 7313, USA
    Subst Abus 25:35-43. 2004
    ..Cigarette smoking is a major co-morbidity of marijuana use and smoking cessation should be addressed among marijuana users in addition to their other illicit drug involvement...
  8. ncbi Smoking cessation services in U.S. methadone maintenance facilities
    Kimber P Richter
    Department of Preventive Medicine and Public Health, University of Kansas Medical Center, Mail Stop 1008, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
    Psychiatr Serv 55:1258-64. 2004
    ..Most patients in drug treatment smoke cigarettes. This study established the prevalence and types of nicotine dependence services offered in methadone and other opioid treatment clinics in the United States...
  9. ncbi Patients' views on smoking cessation and tobacco harm reduction during drug treatment
    Kimber Paschall Richter
    Department of Preventive Medicine and Kansas Cancer Institute, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA
    Nicotine Tob Res 4:S175-82. 2002
    ..Patients have a number of skills from coping with illicit drug dependence that are useful in combating nicotine dependence. Behavioral methods and short-term pharmacotherapy to help patients reduce tobacco exposure should be explored...
  10. ncbi A hierarchy of strategies heroin-using mothers employ to reduce harm to their children
    K P Richter
    Department of Preventive Medicine, University of Kansas Medical School, 3901 Rainbow Boulevard, Kansas City, KS 66160 7313, USA
    J Subst Abuse Treat 19:403-13. 2000
    ..These strategies, derived innovatively from mothers' experiences, provide progressive goals for treatment and can also serve as measures of success. In addition, they may determine how well children fare in drug-affected families...
  11. ncbi A population-based study of cigarette smoking among illicit drug users in the United States
    Kimber Paschall Richter
    Department of Preventive Medicine, University of Kansas School of Medicine, Kansas City, KS 66160, USA
    Addiction 97:861-9. 2002
    ..We describe smoking patterns among illicit drug users, assess whether cigarette smoking is more prevalent among illicit drug users than it is among non-users and explore how smoking relates to level and type of drug use...
  12. ncbi Tobacco use and quit attempts among methadone maintenance clients
    K P Richter
    Department of Preventive Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160 7313, USA
    Am J Public Health 91:296-9. 2001
    ..This study examined tobacco use prevalence, types of tobacco used, interest in quitting, and prior quit attempts among persons in methadone maintenance treatment...
  13. ncbi Smoking cessation pharmacotherapy preferences in rural primary care
    Paula A Cupertino
    University of Kansas Medical Center, Department of Preventive Medicine and Public Health, Kansas City, KS, USA
    Nicotine Tob Res 10:301-7. 2008
    ..Although some comorbid conditions and concurrent drug therapies were considered contraindications, particularly to bupropion, physicians rarely considered these clinically significant risks enough to deny pharmacotherapy...
  14. ncbi Prevalence and predictors of tobacco treatment in an academic medical center
    Babalola Faseru
    Department of Preventive Medicine and Public Health, University of Kansas Medical Center and School of Medicine, Kansas City, Kansas, USA
    Jt Comm J Qual Patient Saf 35:551-7. 2009
    ..A study was conducted to examine the reach of services within a hospital tobacco treatment program and to identify predictors of referral and treatment...
  15. ncbi Smoking reduction practices among African American smokers
    Kolawole S Okuyemi
    Department Family Medicine, Kansas Cancer Institute, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA
    Nicotine Tob Res 4:S167-73. 2002
    ..Smokers not interested in quitting but willing to reduce their smoking should be encouraged to utilize a variety of smoking reduction strategies...
  16. ncbi Differences among African American light, moderate, and heavy smokers
    K S Okuyemi
    Department of Family Medicine, The Kansas Cancer Institute, University of Kansas School of Medicine, Kansas, USA
    Nicotine Tob Res 3:45-50. 2001
    ..Programs are needed to enhance physician intervention in this understudied population of smokers...
  17. ncbi Infection control practices in U.S. burn units
    Amanda E Hodle
    Bureau of Epidemiology and Disease Prevention, Kansas Department of Health and Environment, Topeka, Kansas, USA
    J Burn Care Res 27:142-51. 2006
    ....
  18. ncbi Benefits of and barriers to providing smoking treatment in methadone clinics: findings from a national study
    Robert Mark McCool
    Department of Preventive Medicine, University of Kansas School of Medicine, Kansas City, KS, USA
    Am J Addict 14:358-66. 2005
    ..Addressing these barriers could increase smoking treatment in addictions clinics and save lives...

Research Grants6

  1. Telemedicine for Smoking Cessation in Rural Primary Care
    Kimber P Richter; Fiscal Year: 2010
    ..The potential health impact is large because the prevalence of smoking is high in rural areas, access to smoking cessation services is low, and new rules for Medicare reimbursement creates a strong potential for widespread adoption. ..
  2. Describing and Measuring Tobacco Treatment in Drug Treatment
    Kimber Richter; Fiscal Year: 2007
    ..Project findings will support future policy and research to strengthen tobacco treatment services in substance abuse treatment. ..
  3. Telemedicine for Smoking Cessation in Rural Primary Care
    Kimber Richter; Fiscal Year: 2009
    ..The potential health impact is large because the prevalence of smoking is high in rural areas, access to smoking cessation services is low, and new rules for Medicare reimbursement creates a strong potential for widespread adoption. ..
  4. Telemedicine for Smoking Cessation in Rural Primary Care
    Kimber Richter; Fiscal Year: 2009
    ..The potential health impact is large because the prevalence of smoking is high in rural areas, access to smoking cessation services is low, and new rules for Medicare reimbursement creates a strong potential for widespread adoption. ..